Expert Review of Pharmacoeconomics and Outcomes Research logo Expert Reviews logo

Expert Review of Pharmacoeconomics & Outcomes Research provides expert commentary on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research.

Publisher: Expert Reviews

Volume 3, Number 6, December 2003
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

Pharmacoeconomic studies and the pharmaceutical industry: bias in which direction?
pp. 665-667(3)
Author: Halpern, Michael

Bulletin Board

News in Brief
pp. 669-672(4)

Drug Evaluation

Pharmacoeconomic aspects of memantine (Ebixa®) in the treatment of Alzheimer’s disease
pp. 675-680(6)
Author: Wimo, Anders

Miscellaneous

Self-management programs in chronic obstructive pulmonary disease: are they worthy?
pp. 681-683(3)
Author: Antoniu, Sabina A

Special Report

Usefulness of resource utilization estimates from piggyback studies in rheumatoid arthritis
pp. 685-689(5)
Authors: Evans, Christopher; Crawford, Bruce; Doyle, Joseph

Review

Impact of socioeconomic status on cardiovascular outcomes in Canada
pp. 691-702(12)
Authors: Alter, David A; Brandes, Shana; Irvine, Jane; Iron, Karey

Measurement strategies for indirect costs in economic evaluations
pp. 703-716(14)
Authors: Evans, Christopher; Mertzanis, Polyxane; Abetz, Linda

Methodological issues in the monetary valuation of benefits in healthcare
pp. 717-727(11)
Authors: Ryan, Mandy; Watson, Verity; Amaya-Amaya, Mabelle

Economic considerations and future directions for lung volume reduction surgery
pp. 729-740(12)
Authors: Reed, Anna; Williams, Trevor; Snell, Gregory

Cost-effectiveness of Advair®: fluticasone propionate and salmeterol combination
pp. 741-747(7)
Authors: Tano, Benoit; Pathak, Dev; Hoffmann, Stephen

Cost-effectiveness of community-acquired pneumonia therapy
pp. 749-756(8)
Authors: Foley, Raymond J; Metersky, Mark L

Potential cost-effectiveness of colorectal cancer chemoprevention with nonsteroidal anti-inflammatory drugs
pp. 757-771(15)
Author: Ladabaum, Uri

Economic evaluation of aromatase inhibitors for the treatment of breast cancer
pp. 773-781(9)
Authors: Alousi, Amin M; Stano, Miron; Simon, Michael S

Item response theory and health-related quality of life in cancer
pp. 783-791(9)
Authors: Gershon, Richard; Cella, David; Dineen, Kelly; Rosenbloom, Sarah; Peterman, Amy; Lai, Jin-Shei

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A